摘要
以福建省为"两票制"实施试点为例,对"两票制"实施前后药品流通系统的现状进行分析,从而对两票制改革提出相关政策建议。
Taking Fujian province as a pilot for the implementation of the "two-vote system" as an example,the current situation of the drug circulation system before and after the implementation of the "two-vote system" was analyzed,and relevant policy suggestions were put forward for the reform of the two-vote system.
引文
[1]乔家骏,曾旖旎,傅鸿鹏.“两票制”对药企经济运行及药品价格的影响[J].卫生经济研究,2018(10):62.
[2]何倩,曹丽君.我国药品流通体制的现状、问题及对策[J].中国医疗保险,2012,5(6):56-59.
[3]种银保.现代医疗设备管理现状及其发展趋势[J].医疗卫生装备,2009,30(3):86-90.
[4]黄丽君,干荣富.对药品采购实施两票制的分析与思考[J].上海医药.2016,37(17).
[5]FDA.DSCSA implementation:annual reporting byprescription drug wholesale distributors and third-party logistics providers guidance for industry[EB/OL].[2017-04-25].